Oxford Immunotec Global PLC - Ordinary Shares (OXFD) News

Oxford Immunotec Global PLC - Ordinary Shares (OXFD): $21.99

0.01 (+0.05%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Filter OXFD News Items

OXFD News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

OXFD News Highlights

  • For OXFD, its 30 day story count is now at 5.
  • Over the past 24 days, the trend for OXFD's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • MS, CE and MAR are the most mentioned tickers in articles about OXFD.

Latest OXFD News From Around the Web

Below are the latest news stories about Oxford Immunotec Global PLC that investors may wish to consider to help them evaluate OXFD as an investment opportunity.

Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection

Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, announced that today it has released the T-SPOT.COVID test, a CE marked ELISPOT based test intended for qualitative detection of a cell mediated (T cell) immune response to SARS-CoV-2 in human whole blood. The company has filed an EUA request to the FDA for the test.

Yahoo | March 4, 2021

PerkinElmer, Inc. -- Moody's assigns Baa3 rating to PerkinElmer's notes offering

Rating Action: Moody's assigns Baa3 rating to PerkinElmer's notes offeringGlobal Credit Research - 04 Mar 2021New York, March 04, 2021 -- Moody's Investors Service, ("Moody's") assigned a Baa3 rating to the proposed offering of senior unsecured 10- and 30-year notes of PerkinElmer, Inc. ("PerkinElmer"). There are no changes to Moody's existing ratings of PerkinElmer including the Baa3 senior unsecured long-term rating. The acquisition slightly increases PerkinElmer's financial leverage to close to 3.0x, up from 2.5x in the last twelve months to September 30, 2020.

Yahoo | March 4, 2021

Lifshitz Law Firm, P.C. Announces Investigation of CHNG, MGLN, OBLN, and OXFD

NEW YORK, NY / ACCESSWIRE / February 14, 2021 / Lifshitz Law Firm, P. (NASDAQ:CHNG)Lifshitz Law Firm, P.

Yahoo | February 14, 2021

INVESTIGATION ALERT: Halper Sadeh LLP Investigates CUB, CRHM, GLUU, OXFD, OBLN; Shareholders Are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Yahoo | February 10, 2021

Oxford signs MOU with Green Cross Medical for T-SPOT Discovery SARS-CoV-2 kit

Oxford Immunotec (OXFD) announces it has worked with Green Cross Medical Science South Korea (GC MS) to enter into an MOU to market the research use only T-SPOT Discovery SARS-CoV-2 kit in South Korea.Under the agreement, GC MS will market and sell the product with Oxford Immunotec Korea providing overall support for the T-SPOT Discovery SARS-CoV-2...

Seeking Alpha | February 8, 2021

Oxford Immunotec Updates Their T-SPOT® Discovery SARS-CoV-2 Kit and Include a New Panel to Detect T Cells Reactive to Endemic Coronaviruses

OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announces an update to the configuration of the T-SPOT Discovery SARS-CoV-2 kit. The kit, for research use only, has been updated using the Company’s growing expertise of the T cell response to SARS-CoV-2 infection. The previous T-SPOT Discovery SARS-CoV-2 kit configuration included five antigen wells, each containing a mix of peptides representing target epitopes derived from the virus, with areas of high homology to endemic coronaviruses removed. Using the Company’s growing results database, it has been possible to make improvements to the configuration of the kit. The new configuration includes on...

Yahoo | February 4, 2021

Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders Are Encouraged to Contact the Firm - RP, OXFD, FFG, MDCA, ALXN, CHNG

Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

Yahoo | January 30, 2021

STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

NEW YORK, NY / ACCESSWIRE / January 29, 2021 /Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating: * Oxford Immunotec Global PLC (NASDAQ:OXFD) relating to its proposed sale to PerkinElmer, Inc. Under the terms of the agreement, OXFD shareholders will receive $22.

Yahoo | January 30, 2021

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates COHR, PS, OXFD, HMSY; Shareholders Are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / January 25, 2021 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:Coherent, Inc. (NASDAQ:COHR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Lumentum Holdings Inc.

Yahoo | January 25, 2021

Moore Kuehn Encourages PROS, JWS, OXFD, and CIIC Investors to Contact Law Firm

Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies:

Yahoo | January 25, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!